Combining culture optimization and synthetic biology to improve production and detection of secondary metabolites in
bioactive compounds
biosynthetic gene cluster
chassis strain
myxobacteria
natural products
secondary metabolites
synthetic biology
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
21 Oct 2024
21 Oct 2024
Historique:
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
21
10
2024
Statut:
aheadofprint
Résumé
Microbial secondary metabolites play crucial ecological roles in governing species interactions and contributing to their defense strategies. Their unique structures and potent bioactivities have been key in discovering antibiotics and anticancer drugs. Genome sequencing has undoubtedly revealed that myxobacteria constitute a huge reservoir of secondary metabolites as the well-known producers, actinomycetes. However, because most secondary metabolites are not produced in the laboratory context, the natural products from myxobacteria characterized to date represent only the tip of the iceberg. By combining the engineering of a dedicated
Identifiants
pubmed: 39431896
doi: 10.1128/spectrum.01740-24
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM